A recent
report published by Infinium Global Research on cell therapy market provides
in-depth analysis of segments and sub-segments in the global as well as
regional cell therapy market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional cell therapy market
over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global cell therapy
market. According to the report, the global cell therapy market is projected to
grow at a healthy CAGR over the forecast period of 2019-2025.
Cell therapy
involves the treatment of diseases by injecting, grafting or implanting
cellular material into the patient’s body. Cell therapy is used to treat various
medical conditions, in different organs and operates through several modes of
delivery. The mechanism of action of cell therapy varies from disease to
disease, however, there are two major principles by which cells assist
therapeutic action. This mechanism involves either stem cell engraftment,
differentiation & long term replacement of damaged tissue or cells
releasing soluble factors such as cytokines, chemokines, and growth factors
that facilitate self-healing. Compared to conventional drug therapy, cell
therapy experience less immune rejection and the cells involved in therapy are
easily available. Cell therapy is used to treat ailments including various
types of cancers, cardiac disorders, degenerative neurological and
neuromuscular diseases and immunological disorders.
Increasing
incidences of cancer across the globe is the primary growth factor of the cell
therapy market. Factors such as the growing aging patient population, the rise
in cell therapy transplantations globally, and rising awareness about diseases
are driving the growth of the cell therapy market. Rising funding from the
government to support cell therapy clinical trials and the introduction of
effective guidelines for cell therapy manufacturing is also driving the growth
of the market. Additionally, decreasing prices of stem cell therapies are
leading to increased preference of buyers towards cell therapy. Development of
cell banking services and subsequent expansion of production, storage, and
characterization of cells are improving volumetric capabilities of the cell
therapy market at a global level. However, the high cost of transplantation
treatment and stringent regulatory policies hampers the growth of the cell
therapy market. Automation in cell therapy manufacturing providing intensive
opportunities in the market.
North America
holds a prominent share in the global cell therapy market. The prevalence of
cancer and blood-related disorders coupled with high investments in the
research and development of novel technologies contributes to the growth of the
cell therapy market in the North America region. According to the National
Cancer Institute, in 2018, approximately 1,735,350 new cases of cancer
diagnosed in the United States. Furthermore, North America has a
well-established healthcare infrastructure that acts as an added advantage for
the growth of the cell therapy market in this region. Asia-Pacific region is anticipated to
stimulate the growth of the cell therapy market. The rising awareness about
advanced medicinal therapies in the Asia-Pacific region contributes to the
increasing demand for cell therapy in the Asia-Pacific region.
The report on
global cell therapy market covers segments such as cell type, therapy type,
application, and end-users. On the basis of cell type, the sub-markets include
stem cell, and differentiated cell. On the basis of therapy type, the
sub-markets include allogenic therapies, and autologous therapies. On the basis
of application, the sub-markets include autoimmune diseases, oncology,
dermatology, muscoskeletal therapies, and other applications. On the basis of
end-users, the sub-markets include hospitals and clinics, biotechnology and
pharmaceutical companies, and research institutes.
The report
provides profiles of the companies in the market such as NuVasive, Inc, Kolon
TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Osiris Therapeutics, Inc.,
Stemedica Cell Technologies, Inc., MEDIPOST, Celgene Corporation, ANTEROGEN.CO., LTD, and Vericel Corporation.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of cell therapy market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.